• bit.bio has undertaken a COVID-19 risk assessment and we are COVID secure
  • info@bit.bio
  • +44 (0) 1223 787 297
Bit Bio
    • technology
    • about
      • who we are
      • team
      • spotlights
      • careers
      • sustainability
      • partner with us
    • ioCells
      • ioWild Type Cells
        • ioGlutamatergic Neurons
        • ioSkeletal Myocytes
        • ioGABAergic Neurons
      • ioDisease Model
        • ioGlutamatergic Neurons HTT 50CAG/WT
    • resources
      • bits of bio
      • blog
      • journals
      • posters
      • tutorial videos
      • videos
      • webinars
    • news
    • events
    • contact
    • technology
    • about
      • who we are
      • team
      • spotlights
      • careers
      • sustainability
      • partner with us
    • ioCells
      • ioWild Type Cells
        • ioGlutamatergic Neurons
        • ioSkeletal Myocytes
        • ioGABAergic Neurons
      • ioDisease Model
        • ioGlutamatergic Neurons HTT 50CAG/WT
    • resources
      • bits of bio
      • blog
      • journals
      • posters
      • tutorial videos
      • videos
      • webinars
    • news
    • events
    • contact

    News

    News | bit.bio wins two awards at Cambridge Independent Science and Tech Awards

    News | bit.bio wins two awards at Cambridge Independent Science and Tech Awards

    May 12, 2022

    Published by bit.bio

    read more
    Press release | bit.bio launches Huntington’s disease human cell model

    Press release | bit.bio launches Huntington’s disease human cell model

    May 9, 2022

    Published by bit.bio

    read more
    News | Rahul Singhvi, CEO National Resilience Inc. visits bit.bio labs

    News | Rahul Singhvi, CEO National Resilience Inc. visits bit.bio labs

    May 5, 2022

    Published by bit.bio

    read more
    Podcast | bit.bio CEO featured on the Charles River | Vital Science podcast

    Podcast | bit.bio CEO featured on the Charles River | Vital Science podcast

    Apr 22, 2022

    Published by Charles River Vital Science

    read more
    Article | bit.bio featured in European Biopharmaceutical Review

    Article | bit.bio featured in European Biopharmaceutical Review

    Mar 29, 2022

    Published by EBR

    read more
    Podcast | bit.bio CEO featured on the Built with Biology podcast

    Podcast | bit.bio CEO featured on the Built with Biology podcast

    Mar 25, 2022

    Published by Synbiobeta

    read more
    Podcast | bit.bio CEO featured on the Hightech Ventures podcast

    Podcast | bit.bio CEO featured on the Hightech Ventures podcast

    Mar 17, 2022

    Published by Hightech Ventures

    read more
    Article | bit.bio featured in BioSpace

    Article | bit.bio featured in BioSpace

    Mar 1, 2022

    Published by BioSpace

    read more
    Article | bit.bio featured as case study by Cambridge Judge Business School

    Article | bit.bio featured as case study by Cambridge Judge Business School

    Feb 16, 2022

    Published by Cambridge JBS

    read more
    Page 1 of 8 1 2 3 4 5 »

    Navigation

    • technology
    • about
    • careers
    • partner with us
    • resources
    • news
    • events
    • contact

    Products

    • ioGlutamatergic Neurons
    • ioSkeletal Myocytes
    • ioGABAergic Neurons
    • ioGlutamatergic Neurons HTT

    Subscribe to our newsletter

    ×

    Subscribe to our newsletter

    bit.bio © 2022 | All rights reserved | privacy policy | terms & conditions

    bit.bio © 2021 | All rights reserved
    privacy policy | terms & conditions